[00:00 – 04:08] Dion Kelly
This is Claire. Claire is a six-year-old girl with quadriplegic cerebral palsy. She can’t speak or move, which hinders her ability to use current assistive technologies. Though she’s very smart and capable, her physical limitations often make it difficult for her to communicate and express her abilities. Around the world, there are millions of children like Claire who face similar challenges. Their access to basic human rights, including self-expression, play and independence, is often restricted.
Brain Computer Interfaces, or BCIs, allow users to control devices using their brainwaves, including household appliances and power mobility chairs. However, BCIs and their applications are not yet readily available to the end-users like Claire because the middle component enabling control of these external devices has been confined to research environments.
Our proprietary technology, the Think2Switch, fills this gap in providing a bridge between BCIs and the devices that they can control. Using a BCI headset, a user can think about a desired intention and use that thought to control a switch-adapted device through translation of the thought to action by the Think2Switch.
We’re packaging our Think2Switch with a commercial BCI headset and environmental control device to provide a ready-to-use, plug-and-play solution for children to immediately access their environments and participate in life activities.
We’ve innovatively filled a significant gap in the market with our user-friendly, portable Think2Switch system. Unlike existing middleware solutions that are typically restricted to lab environments, our unique system is portable and ready for immediate plug-and-play application.
Our initial target market is children with quadriplegia, of which there are 36,000 resulting from CP in developed countries alone. Our entry into this market will leverage specialised healthcare networks, therapeutic communities and targeted marketing strategies. Subsequently, we plan to expand our reach to adults with quadriplegia, a demographic of more than nine million individuals in developed countries. This will involve partnerships with rehabilitation centres, adult care facilities and relevant healthcare providers.
Our long-term strategy involves penetrating the mass market of able-bodied children, a demographic of approximately 80 million in North America. In this phase, we’ll leverage mainstream retail channels and broad-based marketing strategies.
With our Think2Switch technology, Claire is actively participating in activities that were once impossible, from baking cookies with her little brothers, to blending her own meals, making lemonade, and even participating in their family tradition of pickling. Claire’s mom said, “It’s a light at the end of the tunnel. The possibilities are endless.”
As one of the few teams globally focused on researching BCIs for children, our multidisciplinary group of clinicians, engineers and business development specialists are leading the way in this untapped market.
With a shared passion for making a difference, we’re driving forward the development of integrated BCI solutions. We believe that everyone deserves equal opportunities and our vision is to foster an inclusive society where this is possible.
Our next goal is to significantly expand access to our product to better serve our primary target market of children with quadriplegia. In order to achieve this, we’re planning to raise a $2 million funding round later this year.
If you’re a passionate investor who shares our vision of an inclusive society, we’d love to start a conversation. We’re also interested in connecting with potential partners and customers who could benefit from our technology. With your support, we can bring BCI to the millions of individuals who need it most.
Let’s work together to create a future where everyone, regardless of their physical abilities, has the chance to express themselves, to play, to create and to live independently.
Are you ready to join us on this journey?